Skip to content

Diagnostic criteria for Multiple Sclerosis: Impact of high field Magnetic Resonance Imaging

Diagnostic criteria for Multiple Sclerosis: Impact of high field Magnetic Resonance Imaging - 3T-CIS Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40083
Enrollment
30
Registered
2013-05-01
Start date
2013-07-04
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MS multiple sclerosis

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: CIS suggestive of MS as defined by the International Panel Age 18-59 years

Exclusion criteria

Exclusion criteria: Vascular, malignant or other immunological diseases at present or in the past medical history;MRI related exclusion criteria: - Claustrophobia - Foreign non MR compatible metal objects in the body - Foreign metal objects in or close to the head - Allergic reaction to contrast administration in the past (only for patients)

Design outcomes

Primary

MeasureTime frame
Primary endpoint of the study is MS lesion count: MR images from standard field 1.5T and high field 3T will be compared using total amount of lesions and region specific amount of lesions.

Secondary

MeasureTime frame
Secondary endpoints of the study: Data on cortical lesions: a double-inversion recovery (DIR) sequence is also included in the scanning protocol. This gray matter specific sequence leads to higher detection of cortical lesions. There is limited data on the quality of DIR at the various field strengths and vendors.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)